These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 5852879

  • 1. Further studies on the metabolic effects of diazoxide.
    Tabachnick II, Gulbenkian A, Seidman F.
    J Pharmacol Exp Ther; 1965 Dec; 150(3):455-62. PubMed ID: 5852879
    [No Abstract] [Full Text] [Related]

  • 2. THE EFFECT OF A BENZOTHIADIAZINE, DIAZOXIDE, ON CARBOHYDRATE METABOLISM.
    TABACHNICK II, GULBENKIAN A, SEIDMAN F.
    Diabetes; 1964 Dec; 13():408-18. PubMed ID: 14210687
    [No Abstract] [Full Text] [Related]

  • 3. [Analysis of the mechanisms implicated in the hyperglycemic action of diazoxide].
    Loubatières A, Mariani MM, Alric R.
    C R Acad Hebd Seances Acad Sci D; 1966 Apr 18; 262(16):1792-5. PubMed ID: 4956486
    [No Abstract] [Full Text] [Related]

  • 4. CONJOINT CLINIC ON DRUGS AND DIABETES.
    WOLFF FW, LANGDON RG.
    J Chronic Dis; 1964 Jul 18; 17():585-96. PubMed ID: 14179660
    [No Abstract] [Full Text] [Related]

  • 5. [Modification of hormonal and enzymatic regulations of carbohydrate metabolism by using benzothiadiazines].
    Senft G.
    Internist (Berl); 1966 Aug 18; 7(8):426-35. PubMed ID: 4294197
    [No Abstract] [Full Text] [Related]

  • 6. The effect of 5-methylpyrazole-3-carboxylic acid on carbohydrate and free fatty acid metabolism.
    Gerritsen GC, Dulin WE.
    J Pharmacol Exp Ther; 1965 Dec 18; 150(3):491-8. PubMed ID: 5852881
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage.
    Guo Z, Bu S, Yu Y, Ghatnekar G, Wang M, Chen L, Bu M, Yang L, Zhu B, Feng Z, Huang Q.
    J Diabetes Complications; 2008 Dec 18; 22(1):46-55. PubMed ID: 18191077
    [Abstract] [Full Text] [Related]

  • 13. Studies concerning the hyperglycemic effects of diazoxide and its mode of action.
    Yabo R, Viktora J, Staquet M, Wolff F.
    Diabetes; 1965 Sep 18; 14(9):591-4. PubMed ID: 5318830
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Studies in the rat on the problem of the diabetogenic effect of saluretics].
    Meng K, Kroneberg G.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Sep 27; 251(5):433-44. PubMed ID: 4221749
    [No Abstract] [Full Text] [Related]

  • 19. DYNAMIC BIOCHEMICAL PROCESSES INVOLVED IN THE PRODUCTION OF FATTY LIVER.
    MAICKEL RP, YAMADA K.
    Adv Enzyme Regul; 1963 Sep 27; 1():235-45. PubMed ID: 14190358
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.